Loading…
NMR mapping of the highly flexible regions of 13C/15N-labeled antibody TTAC-0001-Fab
Monoclonal antibody (mAb) drugs are clinically important for the treatment of various diseases. TTAC-0001 is under development as a new anti-cancer antibody drug targeting VEGFR-2. As the less severe toxicity of TTAC-0001 compared to Bevacizumab, likely due to the decreased in vivo half-life, seems...
Saved in:
Published in: | Journal of biomolecular NMR 2020-07, Vol.74 (6-7), p.311-319 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Monoclonal antibody (mAb) drugs are clinically important for the treatment of various diseases. TTAC-0001 is under development as a new anti-cancer antibody drug targeting VEGFR-2. As the less severe toxicity of TTAC-0001 compared to Bevacizumab, likely due to the decreased in vivo half-life, seems to be related to its structural flexibility, it is important to map the exact flexible regions. Although the
13
C/
15
N-labeled protein is required for NMR analyses, it is difficult to obtain antibody fragments (Fab and scFv) containing disulfide bonds through general cytosolic expression in
Escherichia coli
(
E. coli
). Here, we notably increased the periplasmic expression of the
13
C/
15
N-labeled TTAC-0001-Fab (
13
C/
15
N-TTAC-Fab) through simple isopropyl β-D-1-thiogalactopyranoside (IPTG)-induction at an increased optical density (1.5 OD
600nm
). Through NMR triple resonance experiments, two loop insertions (LI-1 between the V
H
and C
H
1; LI-2 between the V
L
and C
L
) were confirmed to be highly flexible. The additional LIs could be another way to engineer the antibody by changing the pharmacokinetic properties. |
---|---|
ISSN: | 0925-2738 1573-5001 |
DOI: | 10.1007/s10858-020-00313-1 |